We next explored the potential mechanism underlying the anti-tumor activity of Cu(sal)(phen) in vivo by examining the expression levels of the apoptotic proteins Bcl-2, Bcl-xL, survivin and proliferation marker Ki-67 by immunohistochemical staining of the tumors and semi-quantitative image analysis. Here, BIRC5 is linked to neoplasm.